By Synclaire Cruel
Barr Pharmaceuticals Inc. said Thursday it has submitted a revised proposal to U.S. regulators to allow over-the-counter sales of the "morning-after" pill for women 16 years and older.
The FDA, citing concerns about the morning-after-pill's use by young teenagers, rejected over-the-counter sales of the emergency contraception late Thursday, a move that contradicted the recommendation of the agency's advisory panel.
Support Provided By:
Subscribe to Here’s the Deal, our politics newsletter for analysis you won’t find anywhere else.
Thank you. Please check your inbox to confirm.
Additional Support Provided By: